warrant

adcom

Esperion Therapeutics Inc.

movement

It&#39;s annoying to see this kind of price movement and with no communication from the company.

but unfortunately huge volume doesn’t do much for the upward movement.

manipulation

This stock is so manipulated it&#39;s not even funny.

Has anyone seen a more blatantly manipulated stock?

but a total failure by management to not push this manipulation w the SEC.

$ESPR  I am convinced that this game is more manipulated than wrestling .

shareholder

They’re good on 2 things: burning shareholder cash and rewarding themselves for doing nothing.

somethings needs to be fixed in this market - somebody is messing with long-term retail shareholders.

Wow did they screw up a good drug and long term shareholders here!

suck

$ESPR  
Fuck they filed and going out of the market fuck my luck

Good to know the sun still rises and espr still sucks.

Someone dumped shit lod of shares yesterday am, I think Sheldon fucked all of us.

price

The price  
was probably not attractive enough.

They dilute at the worst possible time at all time lows and the price goes up.

$ESPR I am surprised management cared to tell they have no relationship with SV bank… they seem not to care about anything that takes their stock price down.

$ESPR where is the bottom on this?… this price is absurd

The price of a heart heart or heart procedures are outrageous.

Somebody paid a hefty price for that Inclisiran, by the way.

$ESPR This market is so criminal right now I bet you the HFs are just trading shares back and forth between each other to dump the price.

666 seemed like an appropriate price to continue the misery.

but no one cares that you are still neutral on ESPR and that you now think it should have $7 price target instead of your insulting $6 price target.

$ESPR the shorts just got a better deal with their warrants not expiring now for another 3 years and having the option to buy shares on the cheap instead of $9.00.

Yes they get more $ with the warrants and it feels better

share

I personally would like all of the $6 shares

The great option for Dr’s and it is getting destroyed at $6 a share.

But I’ll just say that, again, with a MACE-4 benefit equivalent to a 15% relative risk reduction, we see very significant multiple-fold improvements in market share or penetration and we also have that significant payer benefit.

$ESPR🍀🍀🍀🍀😎😎  Look on the bright side think positive it’s up after hours from the 4 PM close because we purchased shares

$ESPR  me scooping up as many ESPR shares as possible under 7 this morning 
too kind shorts, i appreciate the discount.

$ESPR Bought more shares and options…😳 🤷‍♂️

It’s probably a thank you for your hard work here’s 20000 shares for you coming along with the journey.

$ESPR maintaining buy and the PT from $12 to $22
$3 Today at least

It’s always a “BUY” signal for me as it was again this morning…Our day is coming…🙏🙏🙏

Im in on $RAIN too I like the price action and there are Director insider buys.

This news puts us on the radar for a big buy out.

sale

First oral anti-lipid drug approved with great outcomes in 20 years… once their sales pick up (and they will), this will sky rocket

$ESPR Doesn’t change the fact that this will now set the company toward upward sales and eventually a BO, (yep, 99.9999%) sure of that now.

Sales have increased every quarter and DS are still doing well in Europe.

This is a 31.72 percent increase over sales of $14.41 million the same period last year.

$ESPR On the map, sales will have a nice uptick going forward. https://world-heart-federation.org/wp-content/uploads/WHF-Cholesterol-Roadmap-2022.pdf

$ESPR 4th quarter sales should get a boost from these new recommendations

Intercept Pharmaceuticals Inc

news

Every positive news is shorted to oblivion.

Getting the feeling they will have bad news soon.

No possible good news can come out in months and months

management

Definitely bad management, and a product that almost no one seem to believe in anymore.

Management just needs to get their asses in gear and get the sNDA refiled ASAP.

$ICPT insanity how much incompetence this management has!!!!

Now management’s sluggish pace ensures the downward spiral will continue,

$ICPT unbelievable how much time and money this management has WASTED

And this is a highly risky stock because mgt is not strong and does not communicate.

drug

RETA just did as there wasn&#39;t any treatment for their indication.

I don’t buy that because this was a Trial Drug !!

It’s a shame that no currently approved medications exist for the treatment of NASH

business-result

but it looks like too risky with mixed trials results.

Huge disappointment after nearly a year delay to get bad results. Sigh

but then again they have emphasized they dont need Reverse to submit Regenerate results and no additional safety is what they observed.

company

$ICPT We’re trading like a standalone PBC company, which is ridiculous.

$ICPT Well, looks like this company cannot do good for WS, we are again price as if all failed two month before AdCom.

No one has any confidence in this company, or this is pure manipulation by some greedy parties.

$ICPT this is dumb, the company mentioned many times there will be an adcom

So tired of this company and the way it acts.

I am at a loss, this is surely manipulation, someone wants this company to fail.

$ICPT Clearly the market has no faith in this company.

Let me close by saying incompetence of the company was by a few not a whole

These idiots will announce a delay in resubmitting on the last business day of the year just to guarantee they destroy this company.

$ICPT getting an Adcomm; this is positive, there is no doubt in my mind, that Adcomm panel will understand Risk/Benefit warrants approval.

I predict the Adcom Board will give OCA thumbs up and then a swift approval thereafter.

We are unanimously gonna get the thumbsup at Adcom in light of extensive efficacy and safety data and OCA is gonna be approved before the set Pdufa date unexpectedly.

Adcom is only a positive thing what the company wanted and they have emphasized that numerous times.

approval

So much potential upside if/when approved for NASH.

What approval will do is finally give patients some hope and will put ICPT on the path to long term profitability.

Any weakness today will be recovered quickly by close , their safety profile for OCA is good and should go a long way helping with approval for NASH , my take . GLTA

This will rise and once approved, we&#39;ll get our BO is my guess.

MDGL once it is approved will dominate this market

quot

,&quot; We are really excited about the fixes combination of OCA plus bezafibrate.

So we feel comfortable that the work we&#39;re -- the ground work that we led with PBC will translate very efficiently into a NASH, potential NASH launch.&quot; Linda Richardson

$ICPT &quot;NDA is supported by robust NASH clinical development program, including two positive interim analyses from the Phase 3 REGENERATE study demonstrating OCA&#39;s improvement in liver fibrosis without worsening of NASH&quot;

This efficacy, together with extended exposure in the largest safety database in NASH, supports a positive benefit:risk for OCA in patients with fibrosis due to NASH,&quot;

This is a 16.43 percent increase over sales of $66.64 million the same period last year.&quot;

Importantly, given the recent strategic transactions that have strengthened our capital structure, we are well-positioned financially to manage this critical time while building for the future.&quot;

&quot;This quarter&#39;s performance reinforces the underlying strength and value of our PBC business, and there is significant opportunity to grow this franchise given the number of patients who remain eligible for second-line therapy.

application

This should start the ascent soon in anticipation of FDA outcome which is leaning positive to me , just my take GLTA

$ICPT I am glad the application was accepted, otherwise we would have been at $5, if that

It is obvious that ICPT took care of the issues of concerns from the first application.

In these analyses, OCA 25 mg consistently demonstrated double the response rate of placebo in reduction in liver fibrosis stage without worsening of any of the three histologic components of NASH, an endpoint consistent with FDA&#39;s draft guidance.

“We believe OCA has the potential to become an important therapy given its strong and direct antifibrotic effect, and we look forward to continuing our work with FDA over the coming months as they review our NDA.” $ICPT

Panbela Therapeutics Inc

I’m afraid there are too many Bots &amp; Wimps posting on S/T.

$PBLA High risk of further dilution after the split, de-listing &amp; bankruptcy soon!

F*cking horrible company &amp; management.

$1.3 million on general administration &amp; $2.3 million on R&amp;D. Pretty the PO Box that they use at the local UPS store doesn&#39;t cost that much!

They should legally &amp; criminally be held liable.

CEO, executives &amp; board need to be held accountable!

$PBLA This company is nearly worthless and solely exists to be used as an ATM for the executives &amp; board!

Horribly managed company with greedy executives &amp; board.

wall

Then they put their silly wall getting people even more panicked!

$PBLA in all homesty, 20 cents in ah is possible, walls are paper thin

joke

but on pipeline and outlook cancer trials in tage 3 and 4 million MK what a joke DO NOT SELL NOW I PLEA YOU

It’s just ridiculous that “good news” through out the month took it from 1.25 to 0.78

$PBLA Orphan drug status for their cancer treatment has been granted in the EU only 2 weeks ago…based on the facts current valuation is absolutely ridiculous !

been a quietly ridiculous day actually haha

spike

SPIKE , DROp, DRop, Drop, drop,SPIKE , DROp, DRop, Drop, drop,SPIKE , DROp, DRop, Drop, drop

$PBLA this coulda done so much better today even after that morning spike

$PBLA i just went  through this several times at $TCBP and $GMVD people telling me theyd never bounce off of spikes and they KEEP bouncing.

candlestick

$PBLA warrants conversion going on id say

I take this as a good sign… we run over 100% before we even hit the exercise of warrants and if this is done in short order we could easily have a meme-type run.

$PBLA had a dip as well and looks very promising with Warrants at $3.

but the float and previous explosive patterns of this warrant the respect of all these levels.

$PBLA $PLX $GMDA $OCGN check out $CDTX pdufa March 22nd (ADCOM favor 14-1) , offering done , milestone payment ahead 
Many positive news 💎💎💎

bull

$PBLA I love the bulls that continue to say, bottom is here, it can’t go any lower… lmao!

$PBLA Bulls your patience &amp; ignorance has been rewarded!

This is going to melt so many faces and will give bulls 300%&lt; gains and possible much more.

$PBLA sell the great news and great earnings. .yay

Earring h expected -$3.7 I think they will beat it combine it with some more news and 💥

$PBLA This will open the next few days at $1.5 
News runs 😎

$PBLA So, good news today with patient enrolment begin on yet another trial.

$PBLA Ooh baby..nice news for this sick azz low floater.

In contrary we had good news after other last week.

volume

$PBLA Already 500K over the 10 day volume average, seems to have people interested today.

$PBLA volume today is pretty amazing I must say.

🚨Relative Volume Increase🚨 Part 2

$SGTX $SINT $ZEST $WTER $PBLA 

Stay tuned for more ideas!

$PBLA  PBLA SHORT VOLUME UP TO 71% IS A GOOD SIGNAL

$LMFA Volume has been ascending and can 5-10X.

Top Stocks matching your search for "adcom warrants"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

ESPR

Esperion Therapeutics Inc.

-74.88%

$6.05 - $1.52

Mar, 20, 2023

Jan, 12, 2023

ICPT

Intercept Pharmaceuticals Inc

-34.51%

$20.75 - $13.59

Mar, 10, 2023

Divihomes is Now Live

PBLA

Panbela Therapeutics Inc

-63.19%

$1.44 - $0.53

Mar, 1, 2023

Feb, 13, 2023

ESPR

Esperion Therapeutics Inc.

-74.88%

$6.05 - $1.52

Mar, 20, 2023

Jan, 12, 2023

ICPT

Intercept Pharmaceuticals Inc

-34.51%

$20.75 - $13.59

Mar, 10, 2023

PBLA

Panbela Therapeutics Inc

-63.19%

$1.44 - $0.53

Mar, 1, 2023

Feb, 13, 2023

Jan, 28, 2023

Jan, 18, 2023